Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Scott Tomlins"'
Autor:
Jason Hipp, Steven Christopher Smith, Jerome Cheng, Scott Tomlins, James Monaco, Anant Madabhushi, Priya Kunju, Ulysses J. Balis
Publikováno v:
Analytical Cellular Pathology, Vol 34, Iss 4, Pp 197-203 (2011)
Externí odkaz:
https://doaj.org/article/f064f7c5bc684e8aa2ede78ca1a3b49d
Autor:
Kirsten D. Mertz, Sunita R. Setlur, Saravana M. Dhanasekaran, Francesca Demichelis, Sven Perner, Scott Tomlins, Joëlle Tchinda, Bharathi Laxman, Robert L. Vessella, Rameen Beroukhimt, Charles Lee, Arul M. Chinnaiyan, Mark A. Rubin
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 9, Iss 3, Pp 200-206 (2007)
Recent studies have established that a significant fraction of prostate cancers harbor a signature gene fusion between the 5' region of androgen-regulated TMPRSS2 and an ETS family transcription factor, most commonly ERG. Studies on the molecular mec
Externí odkaz:
https://doaj.org/article/b22d4714166d4200815083b1a3768bb5
Autor:
Udit Singhal, Srinivas Nallandhighal, Jeffrey Tosoian, Trinh Pham, Judith Stangl-Kremser, CJ Lui, Razeem Karim, Komal Plouffe, Todd Morgan, Marcin Cieslik, Roberta Luciano, Shahrokh Shariat, Nadia Finocchio, Lucia Dambrosio, Claudio Doglioni, Arul Chinnaiyan, Scott Tomlins, Alberto Briganti, Ganesh Palapattu, Aaron Udager, Simpa Salami
Localized prostate cancer is composed of multiple spatially distinct tumors with significant inter- and intra-tumoral molecular heterogeneity. This genomic diversity gives rise to many competing subclones that may drive the biological trajectory of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ba28c5b75332a546b789eddc1968436
https://doi.org/10.21203/rs.3.rs-2786222/v1
https://doi.org/10.21203/rs.3.rs-2786222/v1
Autor:
Felix Y. Feng, Eric J. Small, Alan Ashworth, Tomasz M. Beer, Jack Youngren, Charles Ryan, Christopher J. Lord, Karen Knudsen, Scott Tomlins, George Thomas, Colin Pritchard, Morgan Diolaiti, Rajdeep Das, Matti Annala, Kevin Beja, Jacob Schwartzman, Eric Lu, Won Kim, Rahul Aggarwal, Paul Lloyd, Adam Foye, Vishal Kothari, Alexander W. Wyatt, Joshi J. Alumkal, David Quigley
Supplementary Table S1: Patient 1 reversion alleles. Supplementary Table 2: DNA read identifiers supporting reversion alleles. Supplementary Table S3: Gene targets of the SeqCap library used for cfDNA sequencing. Supplementary Figure S1: Frequent los
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f124c125d5ff779f4d55630cba3cda5
https://doi.org/10.1158/2159-8290.22532236
https://doi.org/10.1158/2159-8290.22532236
Autor:
Jeffrey J. Tosoian, Michael S. Sessine, Bruce J. Trock, Ashley E. Ross, Cassie Xie, Yingye Zheng, Nathan L. Samora, Javed Siddiqui, Yashar Niknafs, Zoey Chopra, Scott Tomlins, Lakshmi P. Kunju, Ganesh S. Palapattu, Todd M. Morgan, John T. Wei, Simpa S. Salami, Arul M. Chinnaiyan
Publikováno v:
Prostate Cancer and Prostatic Diseases.
Background Men with persistent risk of Grade Group (GG) ≥ 2 cancer after a negative biopsy present a unique clinical challenge. The validated MyProstateScore test is clinically-available for pre-biopsy risk stratification. In biopsy-naïve patients
Autor:
Jeffrey Tosoian, Michael Sessine, Bruce Trock, Ashley Ross, Cassie Xie, Yingye Zheng, Nathan Samora, Javed Siddiqui, Yashar Niknafs, Zoey Chopra, Scott Tomlins, Lakshmi Kunju, Ganesh Palapattu, Todd Morgan, John Wei, Simpa Salami, Arul Chinnaiyan
Background: Men with persistent risk of Grade Group (GG) ≥2 cancer after a negative biopsy present a unique clinical challenge. The validated MyProstateScore test is clinically-available for pre-biopsy risk stratification. In biopsy-naïve patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b23e607ed85db76794fb4bed17caa774
https://doi.org/10.21203/rs.3.rs-1728404/v1
https://doi.org/10.21203/rs.3.rs-1728404/v1
Autor:
Brittney Cotta, Srinivas Nallandhighal, Judith Stangl-Kremser, Trinh Pham, Jeffrey Tosoian, Kathryn Marchetti, Joel Berends, Mahir Maruf, Scott Tomlins, Todd Morgan, Ganesh Palapattu, Eman Abdulfatah, Aaron Udager, Simpa Salami
Publikováno v:
Journal of Urology. 207
Autor:
Andi Cani, Emily Dolce, Alissa Turnbull, Kevin Hu, Chia-Jen Liu, Elizabeth Darga, Dan Robinson, Yi-Mi Wu, Dafydd G. Thomas, Costanza Paoletti, Scott Tomlins, James Rae, Aaron Udager, Arul Chinnaiyan, Erin F. Cobain, Daniel F. Hayes
Publikováno v:
Cancer Research. 83:P4-02
Clinical decisions on precision and immuno-oncology therapies are based on predictive biomarkers commonly obtained from a single metastatic biopsy or archived primary tumor tissue. Circulating genomic biomarkers offer a minimally invasive approach to
Autor:
Nickolay Khazanov, Melissa Shreve, Laura Lamb, Daniel Hovelson, Marc Matrana, Mark Burkard, Eddy Yang, William Edenfield, Claire Dees, Adedayo Onitilo, Michael Thompson, Gary Buchschacher, Alan Miller, Alexander Menter, Benjamin Parsons, Timothy Wassenaar, Leon Hwang, J. Suga, Robert Siegel, William Irvin, Suresh Nair, Jennifer Slim, Kat Kwiatkowski, Khalis Mitchell, Tina Hu-Seliger, Stephanie Drewery, Andrew Fischer, Jennifer Hipp, Travis Reeder, Hana Vakil, Bryan Johnson, Daniel Rhodes, Scott Tomlins
Pembrolizumab is approved in many advanced solid tumor types, however predictive biomarkers and the proportion of pembrolizumab-benefiting patients vary. Biomarkers beyond PD-L1 immunohistochemistry, microsatellite instability (MSI) status, and tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d44f832c2a2425bf32a36e8fa251391
https://doi.org/10.21203/rs.3.rs-1225960/v1
https://doi.org/10.21203/rs.3.rs-1225960/v1
Autor:
Scott Tomlins, MD
Publikováno v:
Inside Precision Medicine. 9:61-61